CD69 and disease arising from reactivation of latent virus: The inhibition of HIV latent infection of resting T cells did not result from possible drug cytotoxicity, because the short drug treatment did not inhibit T cell function, as judged by the surface expression of CD25 or CD69 following T cell activation (Fig. 6B and D).